Biotech

Free Lab Software Aims to Ease the Data Management Burden for Academic Researchers

UK startup Lab Thread has made its unified lab platform free for small academic and non-profit labs, a move that could lower the barrier to rigorous data management for early-stage biological research.

Antiverse Targets Drug Discovery's "Undruggable" Frontier with AI-Driven Antibodies

AI-designed antibodies could unlock more than half of GPCR targets that have long resisted traditional drug discovery.

Mursla Bio joins ABHI US Accelerator for EvoLiver rollout

Programme will support US market access and early clinical adoption of the company’s liver cancer surveillance blood test.

NICE approves first licensed vitiligo treatment for NHS use in England

First licensed vitiligo therapy underscores opportunities for innovation, pipeline prioritisation, and market access in autoimmune skin disorders.

Axol Bioscience acquires Newcells Biotech ophthalmology business

Deal strengthens Axol’s position as a leading independent provider of human iPSC-derived retinal models for drug discovery and safety testing.

SynGenSys Launches Synthetic Promoter Library for Liver-Targeted Gene Therapies

New synthetic promoter tech promises sharper targeting for liver gene therapies